December 2018

  • Client : BioClin
  • Activity : Medical products for women healthcare
  • Sector : Healthcare
  • Acquired by: Trimb Healthcare
  • Transaction Type: Sell-side

What our client said

“BioClin has grown tremendously and become the largest company in my group of companies. I’m excited we decided to partner with Trimb as they share a mindset like ours. They have a strong ambition and the infrastructure and resources to continue to build our products around the world. We also appreciate Oaklins’ role in helping to make this happen. They were the right party to efficiently manage the process. Highly professional and fun to work with.”

Floris Koumans, Founder and shareholder of BioClin

Orange Pearl International has sold BioClin, a leading healthcare products company, to Trimb Healthcare AB, a Swedish pharmaceutical company.

Based in the Netherlands, BioClin sells products to provide direct treatment and relief for women’s intimate health discomforts. The company’s product portfolio consists of Multi-Gyn, a complete range for treating intimate discomforts and Multi-Mam, a product range of self-care products for mothers and babies. BioClin’s brands are growing rapidly and are sold in pharmacies and drugstores in over 60 countries worldwide.

Trimb Healthcare is rapidly growing pharmaceutical company with a focus on sales, marketing and development of prescription-free OTC pharmaceuticals and consumer healthcare products.

Oaklins’ team in the Netherlands acted as the exclusive sell-side advisor to the shareholders of BioClin in this transaction.

Key Contacts

Other deals in Healthcare